B-Cell Non-Hodgkin Lymphoma (NHL)
Oncology·MeSH: Lymphoma, B-Cell
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| belrapzo | EAGLE PHARMACEUTICALS, INC. (EGRX) |
Phase 2(1)
| Drug | Company |
|---|---|
| tak-007 | TAKEDA PHARMACEUTICAL CO LTD (TKPHF) |
Phase 1/Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for B-Cell Non-Hodgkin Lymphoma (NHL)?
BioSniper tracks 3 drugs in development for B-Cell Non-Hodgkin Lymphoma (NHL) across 2 companies.
How many clinical trials target B-Cell Non-Hodgkin Lymphoma (NHL)?
There are 1 clinical trial targeting B-Cell Non-Hodgkin Lymphoma (NHL) tracked by BioSniper.
Deep-dive into B-Cell Non-Hodgkin Lymphoma (NHL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis